An ω-3-enriched diet alone does not attenuate CCl 4 -induced hepatic fibrosis

1999, Lancet, 354, 447, 10.1016/S0140-6736(99)07072-5 Burr, 1989, Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART), Lancet, 2, 757, 10.1016/S0140-6736(89)90828-3 Nicholson, 2013, The role of marine n-3 fatty acids in improving cardiovascular health: a review, Food Funct, 4, 357, 10.1039/c2fo30235g Yokoyama, 2007, Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis, Lancet, 369, 1090, 10.1016/S0140-6736(07)60527-3 Kim, 2014, Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice, Exp Mol Med, 46, e127, 10.1038/emm.2014.90 Kim, 2013, Dietary omega-3 polyunsaturated fatty acids attenuate hepatic ischemia/reperfusion injury in rats by modulating toll-like receptor recruitment into lipid rafts, Clin Nutr, 32, 855, 10.1016/j.clnu.2012.11.026 Renaud, 2014, Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver — insights into mechanisms of hepatic steatosis, PLoS One, 9, e88584, 10.1371/journal.pone.0088584 Osterreicher, 2012, Xenobiotic-induced liver injury and fibrosis, Expert Opin Drug Metab Toxicol, 8, 571, 10.1517/17425255.2012.674511 Bataller, 2005, Liver fibrosis, J Clin Invest, 115, 209, 10.1172/JCI24282 Czaja, 2014, Hepatic inflammation and progressive liver fibrosis in chronic liver disease, World J Gastroenterol, 20, 2515, 10.3748/wjg.v20.i10.2515 Ramachandran, 2012, Liver fibrosis: a bidirectional model of fibrogenesis and resolution, QJM, 105, 813, 10.1093/qjmed/hcs069 Calder, 2013, N-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions, Proc Nutr Soc, 72, 326, 10.1017/S0029665113001031 Calder, 2011, Fatty acids and inflammation: the cutting edge between food and pharma, Eur J Pharmacol, 668, S50, 10.1016/j.ejphar.2011.05.085 Lopez-Vicario, 2015, Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides, Proc Natl Acad Sci U S A, 112, 536, 10.1073/pnas.1422590112 Ulu, 2013, Anti-inflammatory effects of omega-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension, J Cardiovasc Pharmacol, 62, 285, 10.1097/FJC.0b013e318298e460 Chen, 2013, Docosahexaenoic acid (DHA) ameliorates paraquat-induced pulmonary fibrosis in rats possibly through up-regulation of Smad 7 and SnoN, Food Chem Toxicol, 57, 330, 10.1016/j.fct.2013.03.045 Depner, 2013, Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(−/−) mouse model of Western diet-induced nonalcoholic steatohepatitis, J Nutr, 143, 315, 10.3945/jn.112.171322 Takayama, 2010, Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis, J Oleo Sci, 59, 407, 10.5650/jos.59.407 Poudyal, 2013, Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats, J Nutr Biochem, 24, 1041, 10.1016/j.jnutbio.2012.07.014 Chen, 2013, Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats, Dig Dis Sci, 58, 440, 10.1007/s10620-012-2489-5 Chen, 2012, Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats, J Nutr Biochem, 23, 252, 10.1016/j.jnutbio.2010.11.022 Morimoto, 1994, Fish oil, alcohol, and liver pathology: role of cytochrome P450 2E1, Proc Soc Exp Biol Med, 207, 197, 10.3181/00379727-207-43807 Nanji, 1994, Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats, Alcohol Clin Exp Res, 18, 1280, 10.1111/j.1530-0277.1994.tb00119.x Song, 2008, Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids, J Hepatol, 49, 262, 10.1016/j.jhep.2008.04.023 Weber, 2003, Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model, Crit Rev Toxicol, 33, 105, 10.1080/713611034 Rose, 2010, 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure–activity relationships, pharmacokinetics, and reduction of inflammatory pain, J Med Chem, 53, 7067, 10.1021/jm100691c Ulu, 2014, An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension, J Cardiovasc Pharmacol, 64, 87, 10.1097/FJC.0000000000000094 Papastergiadis, 2012, Malondialdehyde measurement in oxidized foods: evaluation of the spectrophotometric thiobarbituric acid reactive substances (TBARS) test in various foods, J Agric Food Chem, 60, 9589, 10.1021/jf302451c Constandinou, 2005, Modeling liver fibrosis in rodents, Methods Mol Med, 117, 237 Harris, 2015, Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice, Toxicol Appl Pharmacol, 286, 102, 10.1016/j.taap.2015.03.022 Ostermann, 2015, Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): resulting drug levels and modulation of oxylipin pattern, Prostaglandins Other Lipid Mediat, 121, 131, 10.1016/j.prostaglandins.2015.06.005 Zhang, 2014, Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis, Proc Natl Acad Sci U S A, 111, 11127, 10.1073/pnas.1410432111 Morisseau, 2010, Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids, J Lipid Res, 51, 3481, 10.1194/jlr.M006007 Peterson, 1998, Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity, Lipids, 33, 171, 10.1007/s11745-998-0193-y Lee, 1985, Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function, N Engl J Med, 312, 1217, 10.1056/NEJM198505093121903 Calabrese, 2013, Hormetic mechanisms, Crit Rev Toxicol, 43, 580, 10.3109/10408444.2013.808172 Calabrese, 2013, Biphasic dose responses in biology, toxicology and medicine: accounting for their generalizability and quantitative features, Environ Pollut, 182, 452, 10.1016/j.envpol.2013.07.046 Brenner, 2013, Decoding cell death signals in liver inflammation, J Hepatol, 59, 583, 10.1016/j.jhep.2013.03.033 Coelho, 2011, Ischemic preconditioning-like effect of polyunsaturated fatty acid-rich diet on hepatic ischemia/reperfusion injury, J Gastrointest Surg, 15, 1679, 10.1007/s11605-011-1648-x Rao, 1993, Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis in male F344 rats, Carcinogenesis, 14, 1327, 10.1093/carcin/14.7.1327 Nording, 2013, Individual variation in lipidomic profiles of healthy subjects in response to omega-3 fatty acids, PLoS One, 8, e76575, 10.1371/journal.pone.0076575 Schmelzer, 2005, Soluble epoxide hydrolase is a therapeutic target for acute inflammation, Proc Natl Acad Sci U S A, 102, 9772, 10.1073/pnas.0503279102 Kajikawa, 2010, Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats, Dig Dis Sci, 55, 631, 10.1007/s10620-009-1020-0 Tanaka, 2008, Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis, J Clin Gastroenterol, 42, 413, 10.1097/MCG.0b013e31815591aa Depner, 2012, Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr−/− mice, J Nutr, 142, 1495, 10.3945/jn.112.158865 Shaaban, 2014, Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3, Chem Biol Interact, 207, 81, 10.1016/j.cbi.2013.10.008 Alwayn, 2005, Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease, Pediatr Res, 57, 445, 10.1203/01.PDR.0000153672.43030.75 Skorve, 2015, Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice, Lipids Health Dis, 14, 88, 10.1186/s12944-015-0086-2 Titos, 2003, Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis, FASEB J, 17, 1745, 10.1096/fj.02-1157fje Shajari, 2015, Melatonin suppresses activation of hepatic stellate cells through RORalpha-mediated inhibition of 5-lipoxygenase, J Pineal Res, 59, 391, 10.1111/jpi.12271 Chavez, 2010, Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat, Liver Int, 30, 969, 10.1111/j.1478-3231.2010.02256.x Ekor, 2013, Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats, Drug Chem Toxicol, 36, 1, 10.3109/01480545.2011.642380